References
- LiversidgeEMLiversidgeGGDrug nanoparticles: formulating poorly water-soluble compoundsTox Path20083614348
- JunghannsJUMullerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomedicine20083329530918990939
- RaoSSongYPeddieFEvansAMParticle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugsInt J Nanomedicine201161245125121753876
- SunJWangFSuiYEffect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystalsInt J Nanomedicine201275733574423166438
- HuaMHuaXPolymer nanoparticles prepared by supercritical carbon dioxide for in vivo anti-cancer drug deliveryNano Micro Lett201462023
- ChenXZhangJJXuanJZhuJJMyoglobin/gold nanoparticles/carbon spheres 3-D architecture for the fabrication of a novel biosensorNano Res200923210219
- ZhangLSuTHeBGuZSelf-assembly polyrotaxanes nanoparticles as carriers for anticancer drug methotrexate deliveryNano Micro Lett201462108115
- WuLCaiXNelsonKA green synthesis of carbon nanoparticle from honey for real-time photoacoustic imagingNano Res20136531232523824757
- NanJChenYLiRPolymeric hydrogel nanocapsules: a thermo and pH dual-responsive carrier for sustained drug releaseNano Micro Let201463200208
- De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213314918686775
- MurthySKNanoparticles in modern medicine: state of the art and future challengesInt J Nanomedicine20072212914117722542
- OnoueSYamadaSChanHKNanodrugs: pharmacokinetics and safetyInt J Nanomedicine201491025103724591825
- PandeyRSharmaSKhullerGKOral solid lipid nanoparticle-based antitubercular chemotherapyTuberculosis (Edinb)2005855–641542016256437
- HeyderJGebhartJRudolfGSchillerCFStahlhofenWDeposition of particles in the human respiratory tract in the size range 0.005–15 μmJ Aerosol Sci1986175811825
- RaufABhatnagarASisodiaSSKharRKAhmadFJLungs deposition and pharmacokinetic study of submicron budesonide particles in Wistar rats intended for immediate effect in asthmaEXCLI J20171623624428507469
- SungJCPulliamBLEdwardsDANanoparticles or drug delivery to the lungsTrends Biotechnol2007251256357017997181
- DuretCWauthozNSebtiTVanderbistFAmighiKNew inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosisInt J Nanomedicine201275475548923093903
- MansourHMRheeYSWuXNanomedicine in pulmonary deliveryInt J Nanomedicine2009429931920054434
- ZarogoulidisPChatzakiEPorpodisKInhaled chemotherapy in lung cancer: future concept of nanomedicineInt J Nanomedicine201271551157222619512
- ShaoZShaoJTanBTargeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNAInt J Nanomedicine2015101223123325709444
- LeeWHLeeCYTrainiDYoungPMInhalation of nanoparticle-based drug for lung cancer treatment: advantages and challengesYoung Asian J Pharm Sci2015106481489
- ManojSManikanandanSKumaraguruAKNanoparticles: a new technology with wide applicationsRes J Nanosci Nanotech201111111
- ThoratAADalviSVLiquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: Recent developments and future perspectiveChem Eng J2012181–182134
- ShahPUse of nanotechnologies for drug deliveryMRS Bull20063111894899
- Sierra-PallaresJHuddleTGarcía-SernaJUnderstanding bottom-up continuous hydrothermal synthesis of nanoparticles using empirical measurement and computational simulationNano Res201691133773387
- NerowskiAOpitzJBarabanLCunibertiGBottom-up synthesis of ultrathin straight platinum nanowires: electric field impactNano Res201365303311
- Al-KassasRBansalMShawJNanosizing techniques for improving bioavailability of drugsJ Control Release201726020221228603030
- KalaniMYunusRApplication of supercritical antisolvent method in drug encapsulation: a reviewInt J Nanomedicine201161429144221796245
- MatteucciMEHotzeMAJohnstonKPWilliamsRO3rdDrug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilizationLangmuir200622218951895917014140
- HornDRiegerJOrganic nanoparticles in the aqueous phase-theory, experiment, and useAngew Chem Int Ed Engl200140234330436112404417
- GaoLZhangDChenMDrug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery systemJ Nanopart Res2008105845862
- PhanHVCoşkunMBŞeşenMPandraudGNeildAAlanTVibrating membrane with discontinuities for rapid and efficient microfluidic mixingLab Chip201515214206421626381355
- TattersfieldAEHarrisonTWLow-dose budesonide for asthmaLancet200336193631066106712672304
- GodfreySAvitalARoslerAMandelbergAUwyyedKNebulised budesonide in severe infantile asthmaLancet198728563851852
- de JongsteJCDuivermanEJNebulised budesonide in severe childhood asthmaLancet1989186511388
- TurpeinenMPelkonenASSelroosONikanderKHaahtelaTContinuous versus intermittent inhaled corticosteroid (budesonide) for mild persistent asthma in children – not too much, not too littleThorax201267210010222038795
- JacobsCMüllerRHProduction and characterization of a budesonide nanosuspension for pulmonary administrationPharm Res200219218919411883646
- MüllerRHJacobsCKayserONanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the futureAdv Drug Deliv Rev200147131911251242
- AliHWeigmannBNeurathMFCollnotEMWindbergsMLehrCMBudesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseasesJ Control Release201418316717724685705
- XuLMHuTTPuYPreparation of high-performance ultra-fine budesonide particles for pulmonary drug deliveryChem Eng J2014252281287
- LindonJCTrenterGEKoppenaalDEncyclopedia of Spectroscopy and Spectrometry2nd edBurlingtonElsevier2010
- HaoJFFangXSZhouYFDevelopment and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken designInt J Nanomedicine2011668369221556343
- GaltonFMcAlisterBAThe geometric mean, in vital and social statisticsProc R Soc Lond187929365367
- ThøgersenABonsakJFosliCHMuntinghGSize distributions of chemically synthesized Ag nanocrystalsJ App Phys2011110444306
- SabotiDMaverUChanHKPlaninšekONovel budesonide particles for dry powder inhalation prepared using a microfluidic reactor coupled with ultrasonic spray freeze dryingJ Pharm Sci201710671881188828285981
- KaiserALiuTRichteringWSchmidtAMMagnetic capsules and pickering emulsions stabilized by core-shell particlesLangmuir200925137335734119499929
- DalviSVDaveRNControlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitationInd Eng Chem Res2009481675817593
- PandeyKChatteADalviSContinuous production of aqueous suspensions of ultra-fine particles of curcumin using ultrasonically driven mixing devicePharm Dev Technol20172211228117622
- JamshidiRRossiDSaffariNInvestigation of the effect of ultrasound parameters on continuous sonocrystallization in a millifluidic deviceCryst Growth Des201616846074619
- LeeJAshokkumarMKentishSEInfluence of mixing and ultrasound frequency on antisolvent crystallisation of sodium chlorideUltrason Sonochem2014211606823948494
- NiiSTakayanagiSGrowth and size control in anti-solvent crystallization of glycine with high frequency ultrasoundUltrason Sonochem20142131182118624373692
- EsmaeiliMAghajaniMAbbasalipourkabirRAmaniABudesonide-loaded solid lipid nanoparticles for pulmonary delivery: preparation, optimization, and aerodynamic behaviourArtif Cells Nanomed Biotechnol20164481964197126758698